This effect was verified in an in vivo model of ear edema by demonstrating reductions in TSLP, VEGF, MDM2, HIF1α, and NF-κB levels in the serum or ear tissues, along with reductions in redness and ear thickness by the treatment with JRP-SNF102 and FMN. The gene discussed is HIF1A; the disease is edema.